EXoZymes (EXOZ) Stock Price, Quote, News & History

Key Statistics

Open

$5.30

Volume / Avg.

9.37K / 6.97K

Day Range

$5.05 - $5.05

52 Wk Range

4.35 - 18.40

Market Cap

$48.85M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.37%

Days to Cover

2.05

Recent eXoZymes Inc News

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers EXoZymes (NASDAQ:EXOZ) stock increased by 7.5% to $7.18 during Wednesday's after-market session. The market value of their outstanding shares is at $58.5 million. AEON Biopharma (AMEX:AEON) shares rose

Benzinga Insights

12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers Werewolf Therapeutics (NASDAQ:HOWL) stock moved upwards by 77.1% to $0.76 during Thursday's after-market session. The company's market cap stands at $19.8 million. Profusa (NASDAQ:PFSA) stock rose

Benzinga Insights

PRO
eXoZymes Says Optimized NCT Process Delivered 10-Fold Productivity Gain vs. 100-Liter Pilot, With About 67% More Output Per Liter

Benzinga Newsdesk

PRO
eXoZymes Selected To Participate In Inaugural U.S. DOE Genesis Mission; Co. To Collaborate With Lawrence Berkeley National Laboratory On AI-Enabled Digital Twins For Cell-Free Biomanufacturing

Company to collaborate with Lawrence Berkeley National Laboratory on AI-enabled digital twins designed to accelerate optimization of enzyme-driven manufacturing processes.The 9-month project awarded approximately

Benzinga Newsdesk

PRO
eXoZymes Wins $2M NIH Grant To Advance Cannabinoid Analogs For Drug Discovery

Award allows eXoZymes to expand its portfolio of proprietary new-to-nature molecules and potential future pharmaceutical assets and validates the Company's ability to make rare cannabinoids and new cannabinoid-like

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-7.00M

Investing Cash Flow (TTM)

-145.90K

Financing Cash Flow (TTM)

5.81M

Free Cash Flow (TTM)

-7.14M

Capital Expenditure (TTM)

-145.90K

Net Change in Cash (TTM)

-1.33M

Valuation Metrics

Enterprise Value

$44.28M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

13.37

Earnings Yield % (TTM)

-22.86%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.39

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$53.18K

Total Cash

$5.65M

Debt to Equity

0.30

Issuance of Debt (TTM)

-$53.18K

Repayment of Debt (TTM)

-$53.18K

Key Statistics

Open

$5.30

Volume / Avg.

9.37K / 6.97K

Day Range

$5.05 - $5.05

52 Wk Range

4.35 - 18.40

Market Cap

$48.85M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.37%

Days to Cover

2.05

About EXoZymes Inc

Sector

Health Care

Industry

Biotechnology

EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy EXoZymes (EXOZ) stock?

You can purchase shares of EXoZymes (NASDAQ:EXOZ) through any online brokerage.

View our list of the best stock brokerages

Who are EXoZymes (EXOZ) competitors?

Other companies in EXoZymes’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).

What is the forecast, or price target, for EXoZymes (EXOZ) stock?

There is no analysis for EXoZymes to provide a consensus price target.

What is the current price for EXoZymes (EXOZ)?

The stock price for EXoZymes (NASDAQ: EXOZ) is $5.05 last updated October 12, 2026 at 3:59 PM EDT.

Does EXoZymes (EXOZ) pay a dividend?

There are no upcoming dividends for EXoZymes.

When is EXoZymes (NASDAQ:EXOZ) reporting earnings?

EXoZymes does not have any upcoming earnings scheduled.

Is EXoZymes (EXOZ) going to split?

There is no upcoming split for EXoZymes.

What sector and industry does EXoZymes (EXOZ) operate in?

EXoZymes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Key Statistics

Open

$5.30

Volume / Avg.

9.37K / 6.97K

Day Range

$5.05 - $5.05

52 Wk Range

4.35 - 18.40

Market Cap

$48.85M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.37%

Days to Cover

2.05

Recent eXoZymes Inc News

12 Health Care Stocks Moving In Wednesday's After-Market Session

Benzinga Insights

12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga Insights

PRO
eXoZymes Says Optimized NCT Process Delivered 10-Fold Productivity Gain vs. 100-Liter Pilot, With About 67% More Output Per Liter

Benzinga Newsdesk

PRO
eXoZymes Selected To Participate In Inaugural U.S. DOE Genesis Mission; Co. To Collaborate With Lawrence Berkeley National Laboratory On AI-Enabled Digital Twins For Cell-Free Biomanufacturing

Benzinga Newsdesk

PRO
eXoZymes Wins $2M NIH Grant To Advance Cannabinoid Analogs For Drug Discovery

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-7.00M

Investing Cash Flow (TTM)

-145.90K

Financing Cash Flow (TTM)

5.81M

Free Cash Flow (TTM)

-7.14M

Capital Expenditure (TTM)

-145.90K

Net Change in Cash (TTM)

-1.33M

Valuation Metrics

Enterprise Value

$44.28M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

13.37

Earnings Yield % (TTM)

-22.86%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.39

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$53.18K

Total Cash

$5.65M

Debt to Equity

0.30

Issuance of Debt (TTM)

-$53.18K

Repayment of Debt (TTM)

-$53.18K

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy EXoZymes (EXOZ) stock?

You can purchase shares of EXoZymes (NASDAQ:EXOZ) through any online brokerage.

View our list of the best stock brokerages

Who are EXoZymes (EXOZ) competitors?

What is the forecast, or price target, for EXoZymes (EXOZ) stock?

There is no analysis for EXoZymes to provide a consensus price target.

What is the current price for EXoZymes (EXOZ)?

The stock price for EXoZymes (NASDAQ: EXOZ) is $5.05 last updated October 12, 2026 at 3:59 PM EDT.

Does EXoZymes (EXOZ) pay a dividend?

There are no upcoming dividends for EXoZymes.

When is EXoZymes (NASDAQ:EXOZ) reporting earnings?

EXoZymes does not have any upcoming earnings scheduled.

Is EXoZymes (EXOZ) going to split?

There is no upcoming split for EXoZymes.

What sector and industry does EXoZymes (EXOZ) operate in?

EXoZymes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Key Statistics

Open

$5.30

Volume / Avg.

9.37K / 6.97K

Day Range

$5.05 - $5.05

52 Wk Range

4.35 - 18.40

Market Cap

$48.85M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.37%

Days to Cover

2.05

About EXoZymes Inc

Sector

Health Care

Industry

Biotechnology

EXoZymes Inc (EXOZ) Stock Price, Quote, News & History

EXoZymes (EXOZ) Stock Price, Quote, News & History | Benzinga

EXoZymes (EXOZ) Stock Price, Quote, News & History | Benzinga

Key Statistics

Recent eXoZymes Inc News

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

PROeXoZymes Says Optimized NCT Process Delivered 10-Fold Productivity Gain vs. 100-Liter Pilot, With About 67% More Output Per Liter

PROeXoZymes Selected To Participate In Inaugural U.S. DOE Genesis Mission; Co. To Collaborate With Lawrence Berkeley National Laboratory On AI-Enabled Digital Twins For Cell-Free Biomanufacturing

PROeXoZymes Wins $2M NIH Grant To Advance Cannabinoid Analogs For Drug Discovery

Financials

Cash Flows

Valuation Metrics

Company Debt

Key Statistics

About EXoZymes Inc

Edge Rankings

Stock Score Locked: Want to See it?

FAQ

How do I buy EXoZymes (EXOZ) stock?

Who are EXoZymes (EXOZ) competitors?

What is the forecast, or price target, for EXoZymes (EXOZ) stock?

What is the current price for EXoZymes (EXOZ)?

Does EXoZymes (EXOZ) pay a dividend?

When is EXoZymes (NASDAQ:EXOZ) reporting earnings?

Is EXoZymes (EXOZ) going to split?

What sector and industry does EXoZymes (EXOZ) operate in?

Key Statistics

Recent eXoZymes Inc News

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

PROeXoZymes Says Optimized NCT Process Delivered 10-Fold Productivity Gain vs. 100-Liter Pilot, With About 67% More Output Per Liter

PROeXoZymes Selected To Participate In Inaugural U.S. DOE Genesis Mission; Co. To Collaborate With Lawrence Berkeley National Laboratory On AI-Enabled Digital Twins For Cell-Free Biomanufacturing

PROeXoZymes Wins $2M NIH Grant To Advance Cannabinoid Analogs For Drug Discovery

Financials

Cash Flows

Valuation Metrics

Company Debt

Edge Rankings

Stock Score Locked: Want to See it?

FAQ

How do I buy EXoZymes (EXOZ) stock?

Who are EXoZymes (EXOZ) competitors?

What is the forecast, or price target, for EXoZymes (EXOZ) stock?

What is the current price for EXoZymes (EXOZ)?

Does EXoZymes (EXOZ) pay a dividend?

When is EXoZymes (NASDAQ:EXOZ) reporting earnings?

Is EXoZymes (EXOZ) going to split?

What sector and industry does EXoZymes (EXOZ) operate in?

Key Statistics

About EXoZymes Inc

PRO
eXoZymes Says Optimized NCT Process Delivered 10-Fold Productivity Gain vs. 100-Liter Pilot, With About 67% More Output Per Liter

PRO
eXoZymes Selected To Participate In Inaugural U.S. DOE Genesis Mission; Co. To Collaborate With Lawrence Berkeley National Laboratory On AI-Enabled Digital Twins For Cell-Free Biomanufacturing

PRO
eXoZymes Wins $2M NIH Grant To Advance Cannabinoid Analogs For Drug Discovery

PRO
eXoZymes Says Optimized NCT Process Delivered 10-Fold Productivity Gain vs. 100-Liter Pilot, With About 67% More Output Per Liter

PRO
eXoZymes Selected To Participate In Inaugural U.S. DOE Genesis Mission; Co. To Collaborate With Lawrence Berkeley National Laboratory On AI-Enabled Digital Twins For Cell-Free Biomanufacturing

PRO
eXoZymes Wins $2M NIH Grant To Advance Cannabinoid Analogs For Drug Discovery